SCHEMBL9537771

SCHEMBL9537771

CCC(C)c1cn(C(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 6/20 0.41
AGTR2 P50052 6/20 0.41
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9554074 0.94 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9534738 0.89 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9554557 0.89 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9529697 0.89 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9554614 0.88 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9553893 0.88 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9554338 0.88 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9536690 0.88 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9554579 0.87 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9035297 0.87 AGTR1 (0.47) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed